Category Credibility

Two

Two companies, one name

An AI peptide discovery platform that L’Oreal and P&G come to, and an ingredient manufacturer. Both real, both good, and the market is asked to hold both at once. Until that is resolved, every piece of communication has to explain the company before it can sell anything.

Human trials

The asset nobody else has

Three or four ingredients proven in human clinical trials, including work run with Stanford Sports Medicine. In a category where ten thousand products make unproven claims, clinically proven is not a feature. It is the whole argument, and it is currently buried.

Wired

A tier one, spent early

A Wired interview is hard to get and harder to get twice. Spending one before the positioning is settled is the most expensive kind of coverage there is. The next one should land on a company that knows exactly what it is claiming, and why it is the only one who can.

European

The story that is being left on the table

A Dublin AI lab, European science, European ownership of the data. At the moment the company is told to break America first. The more valuable and far less crowded position is to be the European authority in this category, and that is a story told from Europe, not from New York.

FIRST: DEFINE

Settle what Nuritas is, and build the brand architecture that holds it.

One umbrella brand that lifts everything under it, rather than a set of product names competing with their own parent. A category built on the one claim competitors cannot make, clinical proof in humans, and a positioning that separates ingestible, evidenced peptides from the injectables and from the ten thousand things that promise the same result and prove none of it.

THEN: EARN

Make Nuritas the name quoted whenever peptides are discussed seriously.

Trade, business and industry media, where the buyers actually are, rather than beauty blogs. European first, because that is where the differentiated story lives and where the competition is not. A programme built so that every placement compounds the category rather than describing a product.